Oxalates may not be effective in treating dentin hypersensitivity
Ben Balevi B.Eng, D.D.S., Dip EBHC(Oxford), M.Sc.
Systematic Review Conclusion
Current evidence does not support the routine use of oxalates—with the possible exception of 3 percent monohydrogen monopotassium oxalate alone—for the treatment of dentin hypersensitivity (DH) in adults.
Critical Summary Assessment
Results of this well-designed review and comprehensive analysis of the literature show, with the possible exception of 3 percent monohydrogen monopotassium oxalate alone, no significant difference in effectiveness between oxalates and placebo or no treatment in the treatment of DH.
Evidence Quality Rating
This summary is published in the Journal of the American Dental Association and can be accessed at:
Critical Summary Publication Date:
These summaries are not intended to, and do not, express, imply, or summarize standards of care, but rather provide a concise reference for dentists to aid in understanding and applying evidence from the referenced systematic review in making clinically sound decisions as guided by their clinical judgment and by patient needs. American Dental Association © 2019